That's pretty neat.
It's probably too expensive to apply on a large scale, though.
I wonder what would happen if they alter the virus so that it only attacks T-cells and inject the virus directly into patients.
English
-
The expense isn't the issue. At the moment the big issue is that one person that relapsed and died, it means they'll have to go back to the drawing board in order to go through the trails again.